{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-291352","form_type":"8-K","ticker":"NMRA","cik":"0001885522","company_name":"Neumora Therapeutics, Inc.","filed_at":"2025-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.982098+00:00","generated_at":"2026-05-16T17:42:50.119224+00:00","sec_items":["3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"K2HV converts $2.5M loan principal into 2.85M NMRA shares at $0.8774/share","bullets":["K2 HealthVentures converted $2.5M of term-loan principal into 2,849,327 common shares of NMRA at $0.8774/share.","Conversion was exercised under loan agreement dated May 9, 2025, as amended November 4, 2025.","Shares were issued in reliance on Section 4(a)(2) exemption from registration.","Total conversion right under loan agreement remains up to $12.5M; $10M principal remains convertible."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-291352","json":"https://secwatch.observer/filing/0001193125-25-291352.json","markdown":"https://secwatch.observer/filing/0001193125-25-291352.md","text":"https://secwatch.observer/filing/0001193125-25-291352.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1885522/000119312525291352/0001193125-25-291352-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1885522/000119312525291352/d873320d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:42:50.119224+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}